Archives

by in
Entry Author Date Location
East Coast Biotech Roundup: Vertex, Cubist, Editas, Polaris, & More 06/27/14 Boston
Vertex Stock Up 40 Percent After Cystic Fibrosis Trial Results 06/24/14 Boston
East Coast Biotech Roundup: Bluebird, Moderna, Navitor, & More 06/20/14 Boston
East Coast Biotech Roundup: Accelerate LI, ASCO, Akebia, & More 06/09/14 Boston
East Coast Biotech Roundup: Mergers, Rhythm, Regeneron, & More 05/09/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
How A Kidney Drug Almost Torpedoed Concert Pharma’s IPO 04/25/14 Boston
Foresite Capital Reloads With New $300M Late-Stage Biotech Fund 04/01/14 San Francisco
East Coast Biotech Roundup: Dicerna, J&J, Neurophage, & More 01/31/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
East Coast Biotech Roundup: Curoverse, Sia, Trinity, & (Much) More 12/20/13 Boston
Vertex Looks to Patient Subset as CF Drug Misses Mark in Latest Study 12/19/13 Boston
East Coast Biotech Roundup: Moderna, Aileron, Seres, & More 11/22/13 Boston
Vertex Sells Hep C Drug Royalty Rights to Janssen for $152M 11/20/13 Boston
East Coast Biotech Roundup: Vertex, Dimension, Merrimack, & More 11/01/13 Boston
Vertex Cuts 15% of Workforce as Hepatitis C Drug Sales Drop 10/29/13 Boston
The Best Biotech Graduate Schools in Real Life 09/23/13 National
East Coast Biotech Roundup: Cubist, Acetylon, Foundation, & More 08/02/13 Boston
New Data Could Open Vertex’s CF Drug to 400 More Patients 07/29/13 Boston
East Coast Life Sciences Roundup: Sarepta, Agios, Gerngross, & (Much) More 07/26/13 Boston
Vertex Sees Liver Toxicity With Emerging Hep C Drug, Faces FDA Hold 07/25/13 Boston
East Coast Life Sciences Roundup: Celgene, Dunsire, Forma, & More 07/12/13 Boston
Why the Kendall Square Lab and Office Markets Are Out of Whack 05/15/13 Boston
East Coast Life Sciences Roundup: Thermo, Alkermes, Acorda, Epizyme 04/19/13 Boston
Vertex Pharmaceuticals Booms on Cystic Fibrosis Combo Drug Study 04/18/13 Boston
Boston Biotech Seizes the Momentum: Last Chance for Early Bird Tix 03/07/13 Boston
Poll: Which of These 10 New Drugs Is Priced Too High? 02/11/13 National
East Coast Life Sciences Roundup: Sarepta, Vertex, Celsion, More 02/01/13 Boston
If You’ve Got a Real Breakthrough, the FDA Wants To Talk 01/14/13 National
Got Cancer? Sorry, There’s No App for That 01/10/13 Seattle
Page 1 of 10 next page »